Directorate Change

3 April 2018

Assura plc

Directorate Change

Assura plc ("Assura" or "the Company"), the UK's leading primary care property investor and developer, confirms that, further to the announcement made on 3 October 2017, Andrew Darke stepped down from the Board effective 31 March 2018.

The remuneration disclosures required pursuant to section 430(2B) of the Companies Act 2006 will be available on the Company's website as soon as amounts have been finalised.

- Ends -

For more information, please contact:

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high quality patient care in the community. At 30 September 2017, Assura's property portfolio was valued at £1.56 billion.

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association